A new study from the American Academy of Pediatrics now recommends genome and exome sequencing as first-line diagnostic tests for children with neurodevelopmental disorders to improve early diagnoses and ensure comprehensive care. Scott Demarest, MD, Chief Precision Medicine Officer, comments on his experience.
CU Anschutz
Administrative Pavilion
13123 E. 16th Ave.
B065
Aurora, CO 80045